project id: TCGA-BLCA; case submitter id: TCGA-DK-A3X1; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 7.0; age at index: 78; days to birth: -28757; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1931; age at diagnosis: 28757; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2009.0; icd 10 code: C67.1; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Dome of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Dome of bladder; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 1157; days to sample procurement: 0; initial weight: 480.0; portion submitter id: TCGA-DK-A3X1-01A-12; percent lymphocyte infiltration: 6.0; percent monocyte infiltration: 1.0; percent necrosis: 3.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 47.0; percent tumor cells: 50.0; percent tumor nuclei: 70.0;